Age as a prognostic factor in breast cancer

Autor: LAURENCE VANLEMMENS, Hebbar M, Jp, Peyrat, Bonneterre J

Publikováno v: Europe PubMed Central

We retrospectively analysed data from 1751 patients with non-metastatic and non-inflammatory breast cancer treated in our institution between 1977 and 1989, in order to evaluate the link between age and prognosis in breast cancer. We chose three age

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::50998041c60841a537bee36faa552fb0
https://pubmed.ncbi.nlm.nih.gov/9677440

Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors

Autor: JP. Peyrat, J. Bonneterre, Ph. Vennin, H. Jammes, J. Djiane, J. Lefebvre, A. Demaille

Publikováno v: European Journal of Cancer and Clinical Oncology. 26:158

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68f11b3f737e10835ac01d2bb5d725ab
https://doi.org/10.1016/0277-5379(90)90343-r

[P53 antibodies: a new method for the analysis of alterations of the p53 gene: application to breast cancer]

Autor: thierry soussi, Jp, Peyrat, Lubin R, Bonneterre J

Publikováno v: Europe PubMed Central

Alterations in the p53 gene are found in 20% to 40% of breast cancers and are generally associated with factors of adverse prognostic significance. In most instances, point mutations modify the confirmation of p53, causing the gene to accumulate in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::38284a37069eed37aa5b4753df85fb9a
http://europepmc.org/abstract/med/8763583

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].

Autor: Luporsi E; Institut de cancérologie de Lorraine, 6, avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy cedex, France., Bellocq JP; CHRU, 1, place de l'Hôpital, 67000 Strasbourg, France., Barrière J; Centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice, France., Bonastre J; Institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France., Chetritt J; Institut d'histopathologie, 55, rue Amiral-du-Chaffault, 44100 Nantes, France., Le Corroller AG; UMR 912 Inserm, institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, 13009 Marseille, France., de Cremoux P; Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France., Fina F; AP-HM, faculté de médecine-secteur Nord, chemin des Bourrely, 13915 Marseille cedex 20, France., Gauchez AS; CHU Grenoble, 29, avenue Maquis-du-Grésivaudan, 38701 La Tronche, France., Lamy PJ; Institut régional du cancer, 208, avenue des Apothicaires, 34298 Montpellier cedex 5, France., Martin PM; AP-HM, faculté de médecine-secteur Nord, chemin des Bourrely, 13915 Marseille cedex 20, France., Mazouni C; Institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France., Peyrat JP; Centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59000 Lille, France., Romieu G; Institut régional du cancer, 208, avenue des Apothicaires, 34298 Montpellier cedex 5, France., Verdoni L; Institut national du cancer, 52, avenue André-Morizet, 92513 Boulogne-Billancourt cedex, France., Mazeau-Woynar V; Institut national du cancer, 52, avenue André-Morizet, 92513 Boulogne-Billancourt cedex, France., Kassab-Chahmi D; Institut national du cancer, 52, avenue André-Morizet, 92513 Boulogne-Billancourt cedex, France. Electronic address: recommandations@institutcancer.fr.

Publikováno v: Bulletin du cancer [Bull Cancer] 2015 Sep; Vol. 102 (9), pp. 719-29. Date of Electronic Publication: 2015 Jul 30.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Autor: Rebbeck TR; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia2Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Mitra N; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Wan F; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Sinilnikova OM; Centre de Recherche en Cancérologie de Lyon, UMR Inserm, Centre Léon Bérard, Lyon, France., Healey S; Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia., McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Mazoyer S; Centre de Recherche en Cancérologie de Lyon, UMR Inserm, Centre Léon Bérard, Lyon, France., Chenevix-Trench G; Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Nathanson KL; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia6Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Laitman Y; Sheba Medical Center, Tel Aviv, Israel., Kushnir A; Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel Hashomer, Israel., Paluch-Shimon S; Sheba Medical Center, Tel Aviv, Israel., Berger R; Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel., Zidan J; Oncology Institute, Rivkah Ziv Medical Center Zefat, Israel., Friedman E; Sheba Medical Center, Tel Aviv, Israel., Ehrencrona H; Department of Oncology, Lund University, Lund, Sweden12Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Stenmark-Askmalm M; Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden., Einbeigi Z; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Loman N; Department of Oncology, Lund University, Lund, Sweden., Harbst K; Department of Oncology, Lund University, Lund, Sweden., Rantala J; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Melin B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden., Huo D; Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois., Olopade OI; Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois., Seldon J; UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, California., Ganz PA; UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, California., Nussbaum RL; Department of Medicine and Genetics, University of California, San Francisco., Chan SB; Cancer Risk Program, Helen Diller Family Cancer Center, University of California, San Francisco., Odunsi K; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York., Gayther SA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles., Domchek SM; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia6Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Arun BK; University of Texas MD Anderson Cancer Center, Houston., Lu KH; University of Texas MD Anderson Cancer Center, Houston., Mitchell G; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia 25Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City., Pathak H; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City., Ross E; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Daly MB; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California., Whittemore AS; Cancer Risk Program, Helen Diller Family Cancer Center, University of California, San Francisco., John EM; Department of Epidemiology, Cancer Prevention Institute of California, Fremont., Miron A; Dana-Farber Cancer Institute, Boston, Massachusetts., Terry MB; Department of Epidemiology, Columbia University, New York, New York., Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, New York., Goldgar DE; Department of Dermatology, University of Utah School of Medicine, Salt Lake City., Buys SS; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City., Janavicius R; Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology, and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Institute Innovative Medicine Center, Vilnius, Lithuania., Tihomirova L; Latvian Biomedical Research and Study Centre, Riga, Latvia., Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Dorfling CM; Department of Genetics, University of Pretoria, Pretoria, South Africa., van Rensburg EJ; Department of Genetics, University of Pretoria, Pretoria, South Africa., Steele L; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California., Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California., Ding YC; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California., Ejlertsen B; Departments of Oncology or Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Gerdes AM; Departments of Oncology or Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Hansen Tv; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Ramón y Cajal T; Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Osorio A; Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain., Benitez J; Human Genetics Group and Genotyping Unit, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain., Godino J; Hospital clinico Universitario 'Lozano Blesa,' Instituto de investigación sanitaria de Aragón (IIS), Zaragoza, Spain., Tejada MI; Molecular Genetics Laboratory (Department of Genetics), Cruces University Hospital Barakaldo, Bizkaia, Spain., Duran M; Institute of Biology and Molecular Genetics. Universidad de Valladolid (IBGM-UVA), Valladolid, Spain., Weitzel JN; Clinical Cancer Genetics, City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California., Bobolis KA; Clinical Cancer Genetics, City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California., Sand SR; Clinical Cancer Genetics, City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California., Fontaine A; Clinical Cancer Genetics, City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California., Savarese A; Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy., Pasini B; Department of Medical Science, University of Turin, and AO Città della Salute e della Scienza, Turin, Italy., Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy., Zaffaroni D; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Vignolo-Lutati F; AO Città della Salute e della Scienza, Turin, Italy., Scuvera G; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Giannini G; Department of Molecular Medicine, University La Sapienza, Rome, Italy., Bernard L; Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy57Cogentech Cancer Genetic Test Laboratory, Milan, Italy., Genuardi M; Institute of Medical Genetics, Catholic University, 'A. Gemelli' Hospital, Rome, Italy., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy60IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy., Dolcetti R; Cancer Bioimmunotherapy Unit, Centro di Riferimento Oncologico, IRCCSCRO Aviano National Cancer Institute, Aviano (PN), Italy., Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Pensotti V; Cogentech Cancer Genetic Test Laboratory, Milan, Italy60IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy., Gismondi V; Unit of Hereditary Cancer, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy., Yannoukakos D; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos' Aghia Paraskevi Attikis, Athens, Greece., Fostira F; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos' Aghia Paraskevi Attikis, Athens, Greece., Garber J; Dana-Farber Cancer Institute, Boston, Massachusetts., Torres D; Instituto de Genética Humana, Pontificia Universidad Javeriana, Bogotá, Colombia65Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany., Rashid MU; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany 66Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan., Hamann U; Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany., Peock S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Platte R; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Evans DG; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals, NHS Foundation Trust, Manchester, United Kingdom., Eeles R; Oncogenetics Team, Institute of Cancer Research and Royal Marsden, NHS Foundation Trust, London, United Kingdom., Davidson R; Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, United Kingdom., Eccles D; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom., Cole T; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom., Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom., Brewer C; Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, United Kingdom., Hodgson S; Clinical Genetics Department, St Georges Hospital, University of London, United Kingdom., Morrison PJ; Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, United Kingdom., Walker L; Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom., Porteous ME; South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom., Kennedy MJ; Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin and St James's Hospital, Dublin, Eire., Izatt L; South East Thames Regional Genetics Service, Guy's Hospital London, United Kingdom., Adlard J; Yorkshire Regional Genetics Service, Leeds, United Kingdom., Donaldson A; South West Regional Genetics Service, Bristol, United Kingdom., Ellis S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Sharma P; Department of Hematology and Oncology, University of Kansas Medical Center, Kansas City., Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Wappenschmidt B; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Becker A; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Rhiem K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Hahnen E; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Meindl A; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Engert S; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Ditsch N; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Arnold N; Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Germany., Plendl HJ; Institute of Human Genetics, University Medical Center Schleswig-Holstein, Campus Kiel, Germany., Mundhenke C; Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Germany., Niederacher D; Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Fleisch M; Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Sutter C; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Bartram CR; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Dikow N; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Wang-Gohrke S; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Gadzicki D; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany., Steinemann D; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany., Kast K; Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany., Beer M; Institute of Human Genetics, Technical University Dresden, Dresden, Germany., Varon-Mateeva R; Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany., Gehrig A; Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University of Würzburg, Würzburg, Germany., Weber BH; Institute of Human Genetics, University of Regensburg, Regensburg, Germany., Stoppa-Lyonnet D; Institut Curie, Department of Tumour Biology, Paris, France98Institut Curie, INSERM U830, Paris, France99Université Paris Descartes, Sorbonne Paris Cité, France., Sinilnikova OM; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France101INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France., Mazoyer S; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France., Houdayer C; Institut Curie, Department of Tumour Biology, Paris, France99Université Paris Descartes, Sorbonne Paris Cité, France., Belotti M; Institut Curie, Department of Tumour Biology, Paris, France., Gauthier-Villars M; Institut Curie, Department of Tumour Biology, Paris, France., Damiola F; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France., Boutry-Kryza N; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France., Lasset C; Université Lyon 1, CNRS UMR5558, Lyon, France103Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France., Sobol H; Département Oncologie Génétique, Prévention et Dépistage, INSERM CIC-P9502, Institut Paoli-Calmettes/Université d'Aix-Marseille II, Marseille, France., Peyrat JP; Laboratoire d'Oncologie Moléculaire Humaine, Centre Oscar Lambret, Lille, France., Muller D; Unité d'Oncogénétique, CLCC Paul Strauss, Strasbourg, France., Fricker JP; Unité d'Oncogénétique, CLCC Paul Strauss, Strasbourg, France., Collonge-Rame MA; Service de Génétique Biologique-Histologie-Biologie du Développement et de la Reproduction, Centre Hospitalier Universitaire de Besançon, Besançon, France., Mortemousque I; Service de Génétique, Centre Hospitalier Universitaire Bretonneau, Tours, France., Nogues C; Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France., Rouleau E; Laboratoire d'Oncogénétique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France., Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC., De Paepe A; Center for Medical Genetics, Ghent University, Ghent, Belgium., Poppe B; Center for Medical Genetics, Ghent University, Ghent, Belgium., Claes K; Center for Medical Genetics, Ghent University, Ghent, Belgium., De Leeneer K; Center for Medical Genetics, Ghent University, Ghent, Belgium., Piedmonte M; GOG Statistical and Data Center, Buffalo, New York., Rodriguez G; Evanston Hospital, Evanston, Illinois., Wakely K; Tufts University, Medford, Massachusetts., Boggess J; University of North Carolina, Chapel Hill., Blank SV; New York University, New York, New York., Basil J; Ohio State, Good Samaritan Hospital, Cincinnati., Azodi M; Yale University School of Medicine, New Haven, Connecticut., Phillips KA; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia 25Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Caldes T; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain., de la Hoya M; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain., Romero A; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain., Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland., van der Hout AH; Department of Genetics, University Medical Center, Groningen University, Groningen, The Netherlands., Hogervorst FB; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands., Verhoef S; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands., Collée JM; Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands., Seynaeve C; Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands., Oosterwijk JC; Department of Genetics, University Medical Center, Groningen University, Groningen, The Netherlands., Gille JJ; Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands., Wijnen JT; Department of Human Genetics and Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Gómez Garcia EB; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, The Netherlands., Kets CM; Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., Ausems MG; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Aalfs CM; Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands., Devilee P; Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Mensenkamp AR; Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong135Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong136Department of Surgery, University of Hong Kong, Hong Kong., Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Papp J; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Diez O; Oncogenetics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain139University Hospital of Vall d'Hebron, Barcelona, Spain., Lazaro C; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain., Darder E; Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI-Catalan Institute of Oncology, Girona, Spain., Blanco I; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain., Salinas M; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland144Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland., Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Sukiennicki G; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Huzarski T; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Byrski T; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Cybulski C; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Toloczko-Grabarek A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Złowocka-Perłowska E; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Menkiszak J; Department of Surgical Gynecology and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland., Arason A; Department of Pathology, Landspitali University Hospital, Reykjavík, Iceland147BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Barkardottir RB; Department of Pathology, Landspitali University Hospital, Reykjavík, Iceland147BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Simard J; Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center, Quebec City, Quebec, Canada149Laval University, Quebec City, Quebec, Canada., Laframboise R; Medical Genetics Division, Centre Hospitalier Universitaire de Québec, Quebec City, Quebec, Canada151Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy., Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy., Agata S; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy., Alducci E; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy., Peixoto A; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal., Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal153Biomedical Sciences Institute (ICBAS), University of Porto, Portugal., Spurdle AB; Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia., Lee MH; Department of Surgery, Soonchunhyang University and Hospital, Seoul, Korea., Park SK; Department of Preventive Medicine, Seoul National University College of Medicine and Cancer Research Institute, Seoul National University, Seoul, Korea., Kim SW; Department of Surgery, Daerim St Mary's Hospital, Seoul, Korea., Friebel TM; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota159Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Lindor NM; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Pankratz VS; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Guidugli L; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Wang X; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Tischkowitz M; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada161Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom., Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Brno, Czech Republic., Vijai J; Clinical Genetics Service, Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York., Offit K; Clinical Genetics Service, Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York., Robson M; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York., Rau-Murthy R; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York., Kauff N; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York., Fink-Retter A; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Singer CF; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Rappaport C; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Gschwantler-Kaulich D; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Pfeiler G; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Tea MK; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Berger A; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Greene MH; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Mai PL; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Imyanitov EN; N. N. Petrov Institute of Oncology, St Petersburg, Russia., Toland AE; Divison of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus., Senter L; Divison of Human Genetics, Department of Internal Medicine, Comprehensive Cancer Center, Ohio State University, Columbus., Bojesen A; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark., Pedersen IS; Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark., Skytte AB; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark., Sunde L; Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark., Moeller ST; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark., Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark., Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark., Caligo MA; Section of Genetic Oncology, Department of Oncology, University of Pisa and University Hospital of Pisa, Pisa, Italy., Aretini P; Section of Genetic Oncology, Department of Oncology, University of Pisa and University Hospital of Pisa, Pisa, Italy., Teo SH; Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia176Department of Surgery, Faculty of Medicine, University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia., Selkirk CG; NorthShore University HealthSystem, Department of Medicine, Evanston, Illinois., Hulick PJ; NorthShore University HealthSystem, Department of Medicine, Evanston, Illinois., Andrulis I; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada.

Publikováno v: JAMA [JAMA] 2015 Apr 07; Vol. 313 (13), pp. 1347-61.